While MYC amplification is associated with basal breast cancer (see Section 2.1, Figure 1a,b), other subtypes of breast cancer possess the signaling pathways required to deregulate MYC expression independent of this gross genetic abnormality. This evidence concerns the gene MYC and breast carcinoma.